![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Utek Corp. | AMEX:UTK | AMEX | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
UTEK Corporation 30 August 2006 FOR IMMEDIATE RELEASE 30 August 2006 UTEK CORPORATION STRATEGIC ALLIANCE AGREEMENT FOR TECHNOLOGY TRANSFER SIGNED WITH PRACTICEXPERT, INC. Tampa, FL & Calabasas, CA - UTEK Corporation (AMEX & LSE-AIM: UTK), a specialty finance company focused on technology transfer, and PracticeXpert, Inc. (OTC BB: PXPT), a company focused on improving operational efficiencies for medical practitioners, are pleased to announce that they have signed a strategic alliance agreement. Michael Manahan, Chief Executive Officer of PracticeXpert, Inc. said, "Whether we are providing our customers with outsourced medical billing services, or practice management and electronic health records software, the control and deployment of leading edge technologies is a vital component of our product offerings and our competitive strategy. Identifying and acquiring new technologies that improve work flow in a physician's office should allow us to continually improve our products and services, which means more efficient operations and ultimately improved profitability for our physician customers. We are enthused by the potential opportunities this strategic alliance with UTEK Corporation is expected to generate." "UTEK looks forward to working with ParacticeXpert, Inc. to identify and potentially transfer proprietary technologies that will be synergistic with its core business," said Eric Jenkins, Vice President of Strategic Alliances for UTEK Corporation. Through its strategic alliance agreements, UTEK assists companies in enhancing their new product pipeline with the acquisition of proprietary intellectual capital from universities and laboratory research centers. Strategic alliance agreements are generally cancelable by either party with thirty days advance written notice. About PracticeXpert, Inc. PracticeXpert provides turn-key practice management services and technology solutions to medical practitioners that improve operational efficiencies and enhance cash flow. PracticeXpert offerings include medical billing, accounts receivable management, practice management, consulting, seminars, practice management software, electronic medical records software and related services. PracticeXpert bundles its technology applications with its billing and other practice management services to provide a complete and integrated solution to its physician customers. For more information about PracticeXpert, Inc., please visit its website at www.practicexpert.com. About UTEK Corporation UTEK(R) is a specialty finance company focused on technology transfer. UTEK enables companies to acquire innovative technologies from universities and research laboratories worldwide. UTEK facilitates the identification and then finances the acquisition of external technologies for clients in exchange for their equity securities. This unique process is called U2B(R). In addition to its U2B(R) service, UTEK offers companies the tools to search, analyse and manage university intellectual properties. UTEK is a business development company with operations in the United States, United Kingdom and Israel. For more information about UTEK, please visit its website at www.utekcorp.com. CONTACTS: PracticeXpert, Inc. Michael Manahan +1 818-591-0081 UTEK Corporation USA: Tania Bernier +1 813-754-4330 x223 Consulting for Strategic Growth 1 Stan Wunderlich +1 800-625-2236 UK: Bankside +44 20-7367-8888 Steve Liebmann Forward-Looking Statements Certain matters discussed in this press release are "forward-looking statements." These forward-looking statements can generally be identified as such because the context of the statement will include words, such as UTEK or PracticeXpert, Inc. "expects," "should," "believes," "anticipates" or words of similar import. Similarly, statements that describe UTEK's or PracticeXpert, Inc.'s future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties, including the financial performance of UTEK or PracticeXpert, Inc., as appropriate, and the valuation of UTEK's investment portfolio, which could cause actual results to differ materially from those currently anticipated. Although UTEK and PracticeXpert, Inc. believe the expectations reflected in any forward-looking statements are based on reasonable assumptions, they cannot give any assurance that their expectations will be attained. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating any forward-looking statements. Certain factors could cause results and conditions to differ materially from those projected in these forward-looking statements, and some of these factors are discussed below. These factors are not exhaustive. New factors, risks and uncertainties may emerge from time to time that may affect the forward-looking statements made herein. These forward-looking statements are only made as of the date of this press release and both UTEK and PracticeXpert, Inc. do not undertake any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances. UTEK's operating results could fluctuate significantly due to a number of factors. These factors include the small number of transactions that are completed each quarter, the value of individual transactions, the timing of the recognition and the magnitude of unrealised gains and losses, UTEK's dependence on the performance of companies in its portfolio, the possibility that advances in technology could render the technologies it has transferred obsolete, the loss of technology licenses by companies in its portfolio, the degree to which it encounters competition in its markets, the volatility of the stock market and the volatility of the valuations of the companies it has invested in as it relates to its realised and unrealised gains and losses, the concentration of investments in a small number of companies, as well as other general economic conditions. As a result of these and other factors, current results may not be indicative of UTEK's future performance. For more information on UTEK and for a more complete discussion of the risks pertaining to an investment in UTEK, please refer to UTEK's filings with the Securities and Exchange Commission. This information is provided by RNS The company news service from the London Stock Exchange END NRAUKAVRNSRWUAR
1 Year Utek Chart |
1 Month Utek Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions